Cellular Biomedicine Group Inc. Daily Stock Analysis

Daily Stock Analysis, CBMG, Cellular Biomedicine Group Inc, priceseries

Cellular Biomedicine Group Inc. Daily Stock Analysis
Stock Information
Open
8.67
Close
8.65
High
8.95
Low
8.60
Previous Close
8.85
Daily Price Gain
-0.20
YTD High
13.80
YTD High Date
Mar 2, 2017
YTD Low
5.05
YTD Low Date
May 12, 2017
YTD Price Change
-4.55
YTD Gain
-34.47%
52 Week High
15.45
52 Week High Date
Nov 14, 2016
52 Week Low
5.05
52 Week Low Date
May 12, 2017
52 Week Price Change
-5.42
52 Week Gain
-38.52%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 5. 2015
18.72
Mar 25. 2015
43.42
33 Trading Days
131.94%
Link
LONG
May 18. 2015
29.54
Jun 3. 2015
34.11
11 Trading Days
15.48%
Link
LONG
Oct 30. 2015
21.00
Nov 16. 2015
23.30
11 Trading Days
10.95%
Link
LONG
Jun 19. 2017
7.35
Jul 10. 2017
8.59
14 Trading Days
16.87%
Link
Company Information
Stock Symbol
CBMG
Exchange
NasdaqGM
Company URL
http://http://www.cellbiomedgroup.com
Company Phone
(408) 973-7884
CEO
Bizuo Liu
Headquarters
California
Business Address
19925 STEVENS CREEK BLVD., SUITE 100, CUPERTINO, CA 95014
Sector
-
Industry Category
-
Industry Group
-
CIK
0001378624
About

Cellular Biomedicine Group Inc., a biomedicine company, develops stem cell therapies for degenerative diseases and cancerous diseases in Greater China.

Description

Cellular Biomedicine Group Inc., a biomedicine company, develops stem cell therapies for degenerative diseases and cancerous diseases in Greater China. It focuses on developing and marketing cell-based therapies to treat serious chronic and degenerative diseases, such as cancer, osteoarthritis, tissue damage, various inflammatory diseases, and metabolic diseases. The company develops treatments utilizing proprietary cell based technologies, including immune cell therapy for the treatment of a range of cancers; human adipose-derived mesenchymal progenitor cells for the treatment of joint and autoimmune diseases; and tumor cell specific dendritic cell therapy. Cellular Biomedicine Group Inc. was incorporated in 2001 and is headquartered in Cupertino, California.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading